You are here

Heart Failure

 

A model-based study found that patients with chronic heart failure who used the CardioMEMS device had reductions in hospitalizations and increases in quality-adjusted life-years (QALYs) and costs.

 

 

Recent Headlines

Study links alcohol consumption and cardiovascular disorders

Consuming a lot of alcohol has long been associated with heart problems, but a new study offers an uncharted perspective on “wet” counties versus “dry” counties and how living in either can affect cardiovascular health.

Adolescent obesity a strong indicator for middle-age heart failure

Having a higher-than-normal body mass index (BMI) as a teenager could be an indicator that men will experience heart failure in middle age. 

Combination of diabetes and heart failure more deadly than previously realized

Patients who suffer from type 2 diabetes and coronary heart disease could be in worse shape than doctors previously thought, say the authors of a new study published in the journal Diabetes Care.

 
Loneliness and isolation lead to a 30% increased risk in heart disease, stroke

A study published by Heart found that loneliness and social isolation are linked to a 30 percent increased risk of having a stroke or developing coronary artery disease, the two leading causes of death for men and women.

Experimental heart failure medication meets primary endpoint in phase 2b trial

Vericel Corp. announced on March 10 that its experimental drug to treat advanced heart failure due to ischemic dilated cardiomyopathy met the primary endpoint in a phase 2b clinical trial.

Self-care does not improve mortality in chronic heart failure patients

Patients with chronic heart failure and high scores on a global self-care scale had similar rates of long-term, all-cause mortality compared with those with low scores, according to a secondary analysis from two observational prospective studies. 

Recovery Time: Despite Proven Benefits, Cardiac Rehabilitation Remains Underused

AACVPR is working to redefine how cardiac rehabilitation is referred, provided and reimbursed.

Model finds the CardioMEMS device is cost-effective for heart failure patients

A model-based study found that patients with chronic heart failure who used the CardioMEMS device had reductions in hospitalizations and increases in quality-adjusted life-years (QALYs) and costs.

Novartis agrees to pay-for-performance agreements with insurers to cover heart failure drug

Novartis has entered into a pay-for-performance agreement with Cigna to cover sacubitril/valsartan (Entresto), a twice-daily oral medication to treat patients with heart failure and reduced ejection fraction. Aetna also signed a value-based agreement with Novartis based on the drug having similar results as shown in clinical trials, according to a Reuters report.

Exercising and dieting improves exercise capacity but not quality of life in older, obese heart failure patients

After a 20-week regimen that included an improved diet and/or an increased exercise regiment, obese, older adults with heart failure had an increase in exercise capacity, according to a randomized trial conducted at an urban academic medical center. However, the regimen did not have a significant effect on quality of life.

Pages